http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105251062-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac4a747e60a2949ac458ccdbb76fdea |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-91 |
| filingDate | 2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f83a23276ac294c4d9bc443c054bdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_306a212ff074458afe717a5b3d5e167d |
| publicationDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105251062-A |
| titleOfInvention | Combination of topically administered rapamycin and cilostazol for the treatment of vascular disease |
| abstract | The present invention relates to the topical administration of a combination of rapamycin and cilostazol for the treatment of vascular diseases. Medical devices can be coated to minimize or substantially eliminate the response of biological tissue to its introduction into the body. It can be coated with any amount of biocompatible material. A therapeutic drug, agent or compound is mixed with a biocompatible material and attached to at least a portion of the medical device. The therapeutic agent is delivered to the disease site area. Liquid formulations are desirable in regional delivery to increase specific drug efficacy and delivery capacity. Equipment improvements to facilitate endothelialization. Devices for delivering implantable medical devices have improved to reduce the likelihood of damaging them during deployment. Various polymer combinations control the rate of elution of therapeutic drugs, agents and or compounds from implantable medical devices. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111493975-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115192780-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111493975-B |
| priorityDate | 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 596.